Alder BioPharmaceuticals Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | Alder BioPharmaceuticals Inc.

Alder BioPharmaceuticals Inc. | Cash Flow

No data

About Alder BioPharmaceuticals

View Profile

Address	11804 North Creek Parkway South Bothell Washington 98011 United States
Employees	-
Website	http://www.alderbio.com
Updated	07/08/2019
Alder Biopharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company, which discovers, develops, and commercializes various therapeutic antibodies. Its product portfolio includes ALD1910, a preclinical product candidate also in development as a migraine prevention therapy. ALD1910 is a monoclonal antibody that inhibits pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38), another protein that is active in mediating the initiation of migraine; and Clazakizumab, Alder's third program, is a monoclonal antibody candidate that inhibits interleukin-6.